Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

ceftobiprole

ceftobiprole
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Zevtera INJECTION, INTRAVENOUS 667 mg      
Comments:

Zevtera is restricted to Infectious Diseases prescribers and should be used as an alternative when other agents (e.g. ceftaroline) have failed or are not tolerable for the patient (e.g. telavancin).

 

 

Automatic renal adjustment per guidelines. See Antimicrobial Dosing Guideline and Renal Adjustment Policy (Adult) for more information.  CrCl calculation policy available here.

 

Reviewed: Dec 2025    

Ceftobiprole (Zevtera) Spotlight.pdf

Last updated: Jan. 20, 2026






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2026 Rpharmy, LLC ­ All Rights Reserved